Tamami Abe

670 total citations
33 papers, 453 citations indexed

About

Tamami Abe is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Tamami Abe has authored 33 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 22 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Tamami Abe's work include Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (13 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Tamami Abe is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Liver Disease and Transplantation (13 papers) and Hepatocellular Carcinoma Treatment and Prognosis (12 papers). Tamami Abe collaborates with scholars based in Japan, Spain and United States. Tamami Abe's co-authors include Hidekatsu Kuroda, Yudai Fujiwara, Yasuhiro Takikawa, Naohisa Kamiyama, Tamotsu Sugai, Kazuyuki Ishida, Takuma Oguri, Yasuhiro Takikawa, Keisuke Kakisaka and Takayoshi Oikawa and has published in prestigious journals such as PLoS ONE, Hepatology and Radiology.

In The Last Decade

Tamami Abe

29 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamami Abe Japan 13 275 267 69 54 44 33 453
Keiko Hosho Japan 14 214 0.8× 271 1.0× 75 1.1× 72 1.3× 75 1.7× 32 516
Atsushi Nagasaka Japan 12 154 0.6× 158 0.6× 59 0.9× 21 0.4× 66 1.5× 39 368
B.E. Annicchiarico Italy 11 313 1.1× 372 1.4× 59 0.9× 18 0.3× 71 1.6× 29 524
Seung Kak Shin South Korea 11 170 0.6× 156 0.6× 60 0.9× 30 0.6× 30 0.7× 34 289
Jin Ye China 8 283 1.0× 297 1.1× 80 1.2× 31 0.6× 122 2.8× 18 575
Tadashi Sekimoto Japan 13 273 1.0× 291 1.1× 92 1.3× 59 1.1× 20 0.5× 44 388
Young-Sun Kim South Korea 12 157 0.6× 235 0.9× 108 1.6× 32 0.6× 30 0.7× 19 426
Shumei Lin China 14 308 1.1× 270 1.0× 51 0.7× 9 0.2× 86 2.0× 39 506
A Urban Poland 9 152 0.6× 86 0.3× 66 1.0× 33 0.6× 23 0.5× 20 284
Keiko Korenaga Japan 9 171 0.6× 155 0.6× 32 0.5× 34 0.6× 45 1.0× 11 300

Countries citing papers authored by Tamami Abe

Since Specialization
Citations

This map shows the geographic impact of Tamami Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamami Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamami Abe more than expected).

Fields of papers citing papers by Tamami Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamami Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamami Abe. The network helps show where Tamami Abe may publish in the future.

Co-authorship network of co-authors of Tamami Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Tamami Abe. A scholar is included among the top collaborators of Tamami Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamami Abe. Tamami Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuroda, Hidekatsu, Tamami Abe, Keisuke Kakisaka, et al.. (2024). Early Clinical Outcomes of Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma: A Real-World Comparison with First-Line or Later-Line Treatment. Drugs - Real World Outcomes. 11(4). 701–710. 2 indexed citations
2.
Endo, Kei, Keisuke Kakisaka, Tamami Abe, et al.. (2024). Positive impact of obesity on the prognosis of liver cirrhosis. Journal of Gastroenterology and Hepatology. 39(8). 1663–1672. 2 indexed citations
3.
Kakisaka, Keisuke, Takuya Watanabe, Hiroaki Abe, et al.. (2024). Low liver reserve is a risk factor for acute pancreatitis in patients with acute liver failure. Hepatology Research. 55(1). 130–137. 1 indexed citations
4.
Sugimoto, Katsutoshi, Kento Imajo, Hidekatsu Kuroda, et al.. (2024). Microwave ablation vs. single-needle radiofrequency ablation for the treatment of HCC up to 4 cm: A randomized-controlled trial. JHEP Reports. 7(1). 101269–101269. 4 indexed citations
5.
Abe, Hiroaki, Kei Endo, Hidekatsu Kuroda, et al.. (2024). Immune checkpoint inhibitor-associated colitis in unresectable hepatocellular carcinoma: two cases of early onset after treatment with durvalumab plus tremelimumab. Clinical Journal of Gastroenterology. 17(2). 307–310. 1 indexed citations
6.
Kakisaka, Keisuke, Hidekatsu Kuroda, Tamami Abe, et al.. (2023). Coincidental items in the definition of metabolic dysfunction‐associated fatty liver are useful in identifying patients having significant fibrosis with fatty liver. Hepatology Research. 53(9). 857–865. 2 indexed citations
7.
Yoshida, Yuichi, Akiko Suzuki, Tamami Abe, et al.. (2023). Seroprevalence and incidence of hepatitis E virus infection in the general population of Iwate prefecture, Japan: A retrospective cohort study. Hepatology Research. 54(1). 24–31. 4 indexed citations
8.
Kuroda, Hidekatsu, Takuma Oguri, Naohisa Kamiyama, et al.. (2023). Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis. Radiology. 309(1). e230341–e230341. 13 indexed citations
9.
Sasaki, Akira, Akira Umemura, Kazuyuki Ishida, et al.. (2022). The Concept of Indeterminable NASH Inducted by Preoperative Diet and Metabolic Surgery: Analyses of Histopathological and Clinical Features. Biomedicines. 10(2). 453–453. 4 indexed citations
10.
Endo, Kei, Hidekatsu Kuroda, Takayoshi Oikawa, et al.. (2022). Immune Checkpoint Inhibitor-Related Pneumonia in Unresectable Hepatocellular Carcinoma: Two Fatal Cases under Atezolizumab plus Bevacizumab. Liver Cancer. 11(6). 572–575. 1 indexed citations
11.
Kuroda, Hidekatsu, Yudai Fujiwara, Tamami Abe, et al.. (2021). Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis. PLoS ONE. 16(4). e0249493–e0249493. 25 indexed citations
12.
Kuroda, Hidekatsu, et al.. (2021). Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease. Journal of Medical Ultrasonics. 48(4). 471–480. 21 indexed citations
13.
Kuroda, Hidekatsu, Tamami Abe, Yudai Fujiwara, et al.. (2020). Contrast‐Enhanced Ultrasonography–Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure. Hepatology. 73(6). 2455–2467. 14 indexed citations
14.
Abe, Tamami, Yudai Fujiwara, Takuya Okamoto, et al.. (2019). Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma. World Journal of Gastroenterology. 25(19). 2365–2372. 24 indexed citations
15.
Kakisaka, Keisuke, Yuji Suzuki, Yudai Fujiwara, et al.. (2018). Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease. Journal of Gastroenterology. 53(12). 1285–1291. 19 indexed citations
16.
Fujiwara, Yudai, Hidekatsu Kuroda, Tamami Abe, et al.. (2018). The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease. Ultrasound in Medicine & Biology. 44(11). 2223–2232. 115 indexed citations
17.
Abe, Tamami, et al.. (2017). Anomalous inferior mesenteric artery supplying the ascending, transverse, descending, and sigmoid colons. Anatomical Science International. 93(1). 144–148. 9 indexed citations
18.
Kuroda, Hidekatsu, Tamami Abe, Keisuke Kakisaka, et al.. (2016). Visualizing the hepatic vascular architecture using superb microvascular imaging in patients with hepatitis C virus: A novel technique. World Journal of Gastroenterology. 22(26). 6057–6057. 30 indexed citations
19.
Yamashiro, Katsushige, Tamami Abe, Hiroaki Suzuki, et al.. (2016). Voided urine cytology and low-grade urothelial neoplasia of the bladder: factors that influence the sensitivity. Journal of the American Society of Cytopathology. 5(4). 227–234. 3 indexed citations
20.
Yagi, Fumio, et al.. (1997). Purification and carbohydrate-binding specificity of Agrocybe cylindracea lectin. Glycoconjugate Journal. 14(2). 281–288. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keiko Hosho Breakdown of academic impact, for papers by Atsushi Nagasaka Breakdown of academic impact, for papers by B.E. Annicchiarico Breakdown of academic impact, for papers by Seung Kak Shin Breakdown of academic impact, for papers by Jin Ye Breakdown of academic impact, for papers by Tadashi Sekimoto Breakdown of academic impact, for papers by Young-Sun Kim Breakdown of academic impact, for papers by Shumei Lin Breakdown of academic impact, for papers by A Urban Breakdown of academic impact, for papers by Keiko Korenaga
Rankless by CCL
2026